Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q81183669 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000259.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q81183669 | ||
| 024 | ‡a 0000-0002-5048-6075 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q81183669 | ||
| 100 | 0 | ‡a লি ই ‡9 bn | |
| 400 | 0 | ‡a Yi Li ‡c researcher (ORCID 0000-0002-5048-6075) ‡9 en | |
| 670 | ‡a Author's Antioxidant status and energy state of erythrocytes in Alzheimer dementia: probing for markers. | ||
| 670 | ‡a Author's Application of Acyzol in the Context of Zinc Deficiency and Perspectives. | ||
| 670 | ‡a Author's Ca2+ -myristoyl switch in neuronal calcium sensor-1: a role of C-terminal segment. | ||
| 670 | ‡a Author's Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT/mTOR pathway and BCR/ABL gene expression in Ph+ acute lymphoblastic leukemia. | ||
| 670 | ‡a Author's Differential control of the CCAAT/enhancer-binding protein beta (C/EBPbeta) products liver-enriched transcriptional activating protein (LAP) and liver-enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the | ||
| 670 | ‡a Author's Effects of coenzyme Q and creatine supplementation on brain energy metabolism in rats exposed to chronic cerebral hypoperfusion | ||
| 670 | ‡a Author's Immunocytochemical characterization of Alzheimer disease hallmarks in APP/PS1 transgenic mice treated with a new anti-amyloid-β vaccine | ||
| 670 | ‡a Author's Impact of amyloid β25-35 on membrane stability, energy metabolism, and antioxidant enzymes in erythrocytes. | ||
| 670 | ‡a Author's Implication of Gastric Cancer Molecular Genetic Markers in Surgical Practice | ||
| 670 | ‡a Author's Nutlin-3 plus tanshinone IIA exhibits synergetic anti-leukemia effect with imatinib by reactivating p53 and inhibiting the AKT/mTOR pathway in Ph+ ALL. | ||
| 670 | ‡a Author's Oxidative stress induced mitochondrial DNA deletion as a hallmark for the drug development in the context of the cerebrovascular diseases | ||
| 670 | ‡a Author's Preserved protein synthesis in the heart in response to acute fasting and chronic food restriction despite reductions in liver and skeletal muscle. | ||
| 670 | ‡a Author's Reduced glucose uptake and Aβ in brain regions with hyperintensities in connected white matter | ||
| 670 | ‡a Author's The combination of Nutlin-3 and Tanshinone IIA promotes synergistic cytotoxicity in acute leukemic cells expressing wild-type p53 by co-regulating MDM2-P53 and the AKT/mTOR pathway | ||
| 670 | ‡a Author's Unsuspected Intrinsic Property of Melanin to Dissociate Water Can Be Used for the Treatment of CNS Diseases. | ||
| 909 | ‡a (orcid) 0000000250486075 ‡9 1 | ||
| 919 | ‡a unsuspectedintrinsicpropertyofmelanintodissociatewatercanbeusedforthetreatmentofcnsdiseases ‡A Unsuspected Intrinsic Property of Melanin to Dissociate Water Can Be Used for the Treatment of CNS Diseases. ‡9 1 | ||
| 919 | ‡a combinationofnutlin3andtanshinoneiiapromotessynergisticcytotoxicityinacuteleukemiccellsexpressingwildtypep53bycoregulatingmdm2p53andtheaktmtorpathway ‡A The combination of Nutlin-3 and Tanshinone IIA promotes synergistic cytotoxicity in acute leukemic cells expressing wild-type p53 by co-regulating MDM2-P53 and the AKT/mTOR pathway ‡9 1 | ||
| 919 | ‡a reducedglucoseuptakeandaβinbrainregionswithhyperintensitiesinconnectedwhitematter ‡A Reduced glucose uptake and Aβ in brain regions with hyperintensities in connected white matter ‡9 1 | ||
| 919 | ‡a preservedproteinsynthesisintheheartinresponsetoacutefastingandchronicfoodrestrictiondespitereductionsinliverandskeletalmuscle ‡A Preserved protein synthesis in the heart in response to acute fasting and chronic food restriction despite reductions in liver and skeletal muscle. ‡9 1 | ||
| 919 | ‡a oxidativestressinducedmitochondrialdnadeletionasahallmarkforthedrugdevelopmentinthecontextofthecerebrovasculardiseases ‡A Oxidative stress induced mitochondrial DNA deletion as a hallmark for the drug development in the context of the cerebrovascular diseases ‡9 1 | ||
| 919 | ‡a nutlin3plustanshinoneiiaexhibitssynergeticantileukemiaeffectwithimatinibbyreactivatingp53andinhibitingtheaktmtorpathwayinph+all ‡A Nutlin-3 plus tanshinone IIA exhibits synergetic anti-leukemia effect with imatinib by reactivating p53 and inhibiting the AKT/mTOR pathway in Ph+ ALL. ‡9 1 | ||
| 919 | ‡a implicationofgastriccancermoleculargeneticmarkersinsurgicalpractice ‡A Implication of Gastric Cancer Molecular Genetic Markers in Surgical Practice ‡9 1 | ||
| 919 | ‡a impactofamyloidβ2535onmembranestabilityenergymetabolismandantioxidantenzymesinerythrocytes ‡A Impact of amyloid β25-35 on membrane stability, energy metabolism, and antioxidant enzymes in erythrocytes. ‡9 1 | ||
| 919 | ‡a immunocytochemicalcharacterizationofalzheimerdiseasehallmarksinappps1transgenicmicetreatedwithanewantiamyloidβvaccine ‡A Immunocytochemical characterization of Alzheimer disease hallmarks in APP/PS1 transgenic mice treated with a new anti-amyloid-β vaccine ‡9 1 | ||
| 919 | ‡a effectsofcoenzymeqandcreatinesupplementationonbrainenergymetabolisminratsexposedtochroniccerebralhypoperfusion ‡A Effects of coenzyme Q and creatine supplementation on brain energy metabolism in rats exposed to chronic cerebral hypoperfusion ‡9 1 | ||
| 919 | ‡a differentialcontroloftheccaatenhancerbindingproteinbeta100ebpbetaproductsliverenrichedtranscriptionalactivatingproteinlapandliverenrichedtranscriptionalinhibitoryproteinlipandtheregulationofgeneexpressionduringthe ‡A Differential control of the CCAAT/enhancer-binding protein beta (C/EBPbeta) products liver-enriched transcriptional activating protein (LAP) and liver-enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the ‡9 1 | ||
| 919 | ‡a curcuminpotentiatestheantileukemiaeffectsofimatinibbydownregulationoftheaktmtorpathwayandbcrablgeneexpressioninph+acutelymphoblasticleukemia ‡A Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT/mTOR pathway and BCR/ABL gene expression in Ph+ acute lymphoblastic leukemia. ‡9 1 | ||
| 919 | ‡a ca2+myristoylswitchinneuronalcalciumsensor1aroleof100terminalsegment ‡A Ca2+ -myristoyl switch in neuronal calcium sensor-1: a role of C-terminal segment. ‡9 1 | ||
| 919 | ‡a applicationofacyzolinthecontextofzincdeficiencyandperspectives ‡A Application of Acyzol in the Context of Zinc Deficiency and Perspectives. ‡9 1 | ||
| 919 | ‡a antioxidantstatusandenergystateoferythrocytesinalzheimerdementiaprobingformarkers ‡A Antioxidant status and energy state of erythrocytes in Alzheimer dementia: probing for markers. ‡9 1 | ||
| 996 | ‡2 NTA|36415439X | ||
| 996 | ‡2 ISNI|0000000044368836 | ||
| 996 | ‡2 BNF|15121891 | ||
| 996 | ‡2 ISNI|0000000051926365 | ||
| 996 | ‡2 CYT|AC000215206 | ||
| 996 | ‡2 NUKAT|n 2017245318 | ||
| 996 | ‡2 LC|no2014140131 | ||
| 996 | ‡2 SZ|1220038393 | ||
| 996 | ‡2 NII|DA11065799 | ||
| 996 | ‡2 ISNI|0000000498752541 | ||
| 996 | ‡2 SUDOC|103973672 | ||
| 996 | ‡2 ISNI|0000000114005898 | ||
| 996 | ‡2 DNB|1266090967 | ||
| 996 | ‡2 CYT|AC000634915 | ||
| 996 | ‡2 LC|n 85054271 | ||
| 996 | ‡2 ISNI|0000000081844037 | ||
| 996 | ‡2 NSK|000745670 | ||
| 996 | ‡2 DNB|1274390559 | ||
| 996 | ‡2 ISNI|0000000079102544 | ||
| 996 | ‡2 SUDOC|115340742 | ||
| 996 | ‡2 DNB|1217608958 | ||
| 996 | ‡2 DNB|1201584329 | ||
| 996 | ‡2 DNB|1245004808 | ||
| 996 | ‡2 DNB|1161829423 | ||
| 996 | ‡2 ISNI|000000045469823X | ||
| 996 | ‡2 LC|n 2023007186 | ||
| 996 | ‡2 DNB|1240339720 | ||
| 996 | ‡2 ISNI|0000000063571522 | ||
| 996 | ‡2 ISNI|0000000500681579 | ||
| 996 | ‡2 LC|n 2018058950 | ||
| 996 | ‡2 ISNI|0000000074299341 | ||
| 996 | ‡2 DNB|123127011X | ||
| 996 | ‡2 CYT|AC000651820 | ||
| 996 | ‡2 CAOONL|ncf10346172 | ||
| 996 | ‡2 CYT|AC000639048 | ||
| 996 | ‡2 NUKAT|n 2017050135 | ||
| 996 | ‡2 CYT|AC000652777 | ||
| 996 | ‡2 DNB|117500100 | ||
| 996 | ‡2 CYT|AC000442111 | ||
| 996 | ‡2 PLWABN|9813204152805606 | ||
| 996 | ‡2 BNF|15737005 | ||
| 996 | ‡2 NUKAT|n 2018128300 | ||
| 996 | ‡2 ISNI|0000000110581468 | ||
| 996 | ‡2 LC|no2003128413 | ||
| 996 | ‡2 NKC|xx0177051 | ||
| 996 | ‡2 DNB|140581316 | ||
| 996 | ‡2 CYT|AC000613007 | ||
| 996 | ‡2 LC|no2019115283 | ||
| 996 | ‡2 SUDOC|228304326 | ||
| 996 | ‡2 RERO|A005493979 | ||
| 996 | ‡2 SIMACOB|433306627 | ||
| 996 | ‡2 SUDOC|031718892 | ||
| 996 | ‡2 DNB|132707494X | ||
| 996 | ‡2 ISNI|0000000047974057 | ||
| 996 | ‡2 BNF|15968092 | ||
| 996 | ‡2 BNF|16958113 | ||
| 996 | ‡2 CYT|AC000648587 | ||
| 996 | ‡2 DNB|1234118386 | ||
| 996 | ‡2 ISNI|0000000066173853 | ||
| 996 | ‡2 DNB|1341489205 | ||
| 996 | ‡2 ISNI|0000000063163043 | ||
| 996 | ‡2 ISNI|0000000063681190 | ||
| 996 | ‡2 DNB|1022968319 | ||
| 996 | ‡2 CYT|AC000635677 | ||
| 996 | ‡2 CYT|AC000658911 | ||
| 996 | ‡2 ISNI|0000000444566161 | ||
| 996 | ‡2 CYT|AC000503751 | ||
| 996 | ‡2 CYT|AC000505827 | ||
| 996 | ‡2 LC|n 2019056859 | ||
| 996 | ‡2 NDL|01117767 | ||
| 996 | ‡2 DNB|1149075538 | ||
| 996 | ‡2 ISNI|0000000453826770 | ||
| 996 | ‡2 CYT|AC000560299 | ||
| 996 | ‡2 LC|nb2006015088 | ||
| 996 | ‡2 DNB|1244306347 | ||
| 996 | ‡2 NII|DA10953004 | ||
| 996 | ‡2 KRNLK|KAC200307555 | ||
| 996 | ‡2 LC|no2004122768 | ||
| 996 | ‡2 DNB|1153859378 | ||
| 996 | ‡2 DNB|1332685145 | ||
| 996 | ‡2 DNB|1323468536 | ||
| 996 | ‡2 NSK|000679413 | ||
| 996 | ‡2 LC|no2014160773 | ||
| 996 | ‡2 DNB|1203639120 | ||
| 996 | ‡2 DNB|1061222713 | ||
| 996 | ‡2 RERO|A025773742 | ||
| 996 | ‡2 ISNI|0000000353426059 | ||
| 996 | ‡2 DNB|1123034699 | ||
| 996 | ‡2 DNB|1274257549 | ||
| 996 | ‡2 NSK|000707124 | ||
| 996 | ‡2 CAOONL|ncf10067908 | ||
| 996 | ‡2 PLWABN|9810604984405606 | ||
| 996 | ‡2 NTA|33924514X | ||
| 996 | ‡2 CYT|AC000652617 | ||
| 996 | ‡2 NUKAT|n 2010121060 | ||
| 996 | ‡2 NUKAT|n 2017065010 | ||
| 996 | ‡2 NII|DA11531064 | ||
| 996 | ‡2 CYT|AC000215695 | ||
| 996 | ‡2 DNB|1324211334 | ||
| 996 | ‡2 DNB|141081414 | ||
| 996 | ‡2 NUKAT|n 2022002730 | ||
| 996 | ‡2 PLWABN|9810596472305606 | ||
| 996 | ‡2 LC|no2015145535 | ||
| 996 | ‡2 ISNI|0000000083002036 | ||
| 996 | ‡2 NLA|000035345633 | ||
| 996 | ‡2 DNB|140689451 | ||
| 996 | ‡2 CYT|AC000345120 | ||
| 996 | ‡2 DNB|1127009346 | ||
| 996 | ‡2 CYT|AC000643730 | ||
| 996 | ‡2 DNB|1190671190 | ||
| 996 | ‡2 SUDOC|169766071 | ||
| 996 | ‡2 ISNI|0000000442652541 | ||
| 996 | ‡2 NTA|287767930 | ||
| 996 | ‡2 DNB|1238097715 | ||
| 996 | ‡2 ISNI|0000000121229187 | ||
| 996 | ‡2 CYT|AC000639861 | ||
| 996 | ‡2 DNB|132644137X | ||
| 996 | ‡2 DNB|1072242435 | ||
| 996 | ‡2 ISNI|0000000044692679 | ||
| 996 | ‡2 PLWABN|9810629803505606 | ||
| 996 | ‡2 NII|DA16533533 | ||
| 996 | ‡2 PLWABN|9810547331605606 | ||
| 996 | ‡2 NSK|000594537 | ||
| 996 | ‡2 DNB|1264953801 | ||
| 996 | ‡2 LC|no2014018137 | ||
| 996 | ‡2 BNF|17786265 | ||
| 996 | ‡2 DNB|1296384829 | ||
| 996 | ‡2 DNB|136316972 | ||
| 996 | ‡2 ISNI|0000000107836933 | ||
| 996 | ‡2 RERO|A018505503 | ||
| 996 | ‡2 LC|n 83074297 | ||
| 996 | ‡2 CYT|AC000402354 | ||
| 996 | ‡2 ISNI|000000004875470X | ||
| 996 | ‡2 ISNI|0000000498921480 | ||
| 996 | ‡2 LC|nr2006022132 | ||
| 996 | ‡2 NTA|140587918 | ||
| 996 | ‡2 ISNI|0000000122755656 | ||
| 996 | ‡2 LC|no2014161020 | ||
| 996 | ‡2 CYT|AC000659659 | ||
| 996 | ‡2 ISNI|0000000051424402 | ||
| 996 | ‡2 DNB|1050811879 | ||
| 996 | ‡2 LC|n 2011017700 | ||
| 996 | ‡2 CYT|AC000653664 | ||
| 996 | ‡2 CYT|AC000651968 | ||
| 996 | ‡2 CYT|AC000659022 | ||
| 996 | ‡2 LC|n 2018068570 | ||
| 996 | ‡2 DNB|1331705789 | ||
| 996 | ‡2 NUKAT|n 2013140840 | ||
| 996 | ‡2 CYT|AC000639173 | ||
| 996 | ‡2 NTA|344715264 | ||
| 996 | ‡2 NTA|320749711 | ||
| 996 | ‡2 CYT|AC660155 | ||
| 996 | ‡2 CYT|AC000643368 | ||
| 996 | ‡2 SUDOC|026989492 | ||
| 996 | ‡2 BNF|17918173 | ||
| 996 | ‡2 SZ|1153859378 | ||
| 996 | ‡2 CYT|AC000643367 | ||
| 996 | ‡2 DNB|1321989881 | ||
| 996 | ‡2 BNF|16197269 | ||
| 996 | ‡2 DNB|1232277355 | ||
| 996 | ‡2 NSK|000677331 | ||
| 996 | ‡2 SUDOC|227102118 | ||
| 996 | ‡2 CAOONL|ncf10265316 | ||
| 996 | ‡2 NSK|000677206 | ||
| 996 | ‡2 DNB|1299327567 | ||
| 996 | ‡2 CYT|AC000548853 | ||
| 996 | ‡2 ISNI|0000000046737068 | ||
| 996 | ‡2 ISNI|0000000121396225 | ||
| 996 | ‡2 NII|DA1845992X | ||
| 996 | ‡2 LC|n 2023180540 | ||
| 996 | ‡2 CYT|AC000636264 | ||
| 996 | ‡2 DNB|1293662674 | ||
| 996 | ‡2 ISNI|000000001987485X | ||
| 996 | ‡2 CYT|AC000652866 | ||
| 996 | ‡2 CYT|AC000631196 | ||
| 996 | ‡2 DNB|1074903420 | ||
| 996 | ‡2 BNF|18171774 | ||
| 996 | ‡2 ISNI|0000000047561615 | ||
| 996 | ‡2 DNB|1158557590 | ||
| 996 | ‡2 DNB|1274243254 | ||
| 996 | ‡2 CYT|AC000499348 | ||
| 996 | ‡2 LC|n 2003067096 | ||
| 996 | ‡2 LC|n 2018008329 | ||
| 996 | ‡2 J9U|987007386742605171 | ||
| 996 | ‡2 LC|no2007055342 | ||
| 996 | ‡2 LC|no2007055343 | ||
| 996 | ‡2 CYT|AC000647969 | ||
| 996 | ‡2 ISNI|0000000077384920 | ||
| 996 | ‡2 ISNI|0000000063205194 | ||
| 996 | ‡2 LC|n 81075694 | ||
| 996 | ‡2 LC|n 2018003984 | ||
| 996 | ‡2 LC|no2013040984 | ||
| 996 | ‡2 J9U|987007347122805171 | ||
| 996 | ‡2 ISNI|0000000501768908 | ||
| 996 | ‡2 CYT|AC000653242 | ||
| 996 | ‡2 DNB|1144369908 | ||
| 996 | ‡2 LC|n 85203070 | ||
| 996 | ‡2 DNB|1053307470 | ||
| 996 | ‡2 CYT|AC000663155 | ||
| 996 | ‡2 BNF|17718073 | ||
| 996 | ‡2 CAOONL|ncf10375343 | ||
| 996 | ‡2 BIBSYS|90541814 | ||
| 996 | ‡2 NTA|14053783X | ||
| 996 | ‡2 PLWABN|9810697331705606 | ||
| 996 | ‡2 NKC|xx0249702 | ||
| 996 | ‡2 ISNI|0000000075457196 | ||
| 996 | ‡2 CAOONL|ncf12128288 | ||
| 996 | ‡2 CYT|AC000643464 | ||
| 996 | ‡2 CYT|AC000215756 | ||
| 996 | ‡2 CYT|AC000215754 | ||
| 996 | ‡2 ISNI|0000000055231165 | ||
| 996 | ‡2 ISNI|0000000064352911 | ||
| 996 | ‡2 NUKAT|n 2015155547 | ||
| 996 | ‡2 NUKAT|n 2012214922 | ||
| 996 | ‡2 CYT|AC000659500 | ||
| 996 | ‡2 LC|n 2017030336 | ||
| 996 | ‡2 RERO|A021643422 | ||
| 996 | ‡2 SUDOC|172231663 | ||
| 996 | ‡2 DNB|1261942221 | ||
| 996 | ‡2 NII|DA10794002 | ||
| 996 | ‡2 SUDOC|113047347 | ||
| 996 | ‡2 CYT|AC000639622 | ||
| 996 | ‡2 NTA|304832189 | ||
| 996 | ‡2 DNB|1189170639 | ||
| 996 | ‡2 LC|n 88109669 | ||
| 996 | ‡2 LC|n 2004154182 | ||
| 996 | ‡2 DNB|1161893687 | ||
| 996 | ‡2 DNB|1283864568 | ||
| 996 | ‡2 LC|no2011014480 | ||
| 996 | ‡2 DNB|171897986 | ||
| 996 | ‡2 NTA|074820958 | ||
| 996 | ‡2 PLWABN|9811769723005606 | ||
| 996 | ‡2 DNB|1339414309 | ||
| 996 | ‡2 CYT|AC000643251 | ||
| 996 | ‡2 BNF|11889753 | ||
| 996 | ‡2 CYT|AC000637235 | ||
| 996 | ‡2 DNB|1146557728 | ||
| 996 | ‡2 LC|no2020092167 | ||
| 996 | ‡2 NII|DA02683797 | ||
| 996 | ‡2 LC|no2022021315 | ||
| 996 | ‡2 LC|no2017147624 | ||
| 996 | ‡2 SZ|1096836998 | ||
| 996 | ‡2 SUDOC|142915270 | ||
| 996 | ‡2 SZ|1050811879 | ||
| 996 | ‡2 J9U|987007429334605171 | ||
| 996 | ‡2 SUDOC|174328133 | ||
| 996 | ‡2 NII|DA02473080 | ||
| 996 | ‡2 NSK|000678053 | ||
| 996 | ‡2 DNB|140479082 | ||
| 996 | ‡2 CYT|AC000647418 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
